Isomorphic Labs

United Kingdom · Biotech · AI

Builds an AI-first drug design engine to accelerate discovery and development across multiple therapeutic areas

Funding history

2 rounds · 2 with disclosed amounts
AnnouncedRoundAmountInvestors
Series C$5BGreenoaks — LeadSequoia Capital — LeadAlphabet — ParticipantAndreessen Horowitz (a16z) — ParticipantCapitalG — ParticipantGV — ParticipantMGX — ParticipantTemasek — ParticipantThrive Capital — ParticipantUK Sovereign AI fund — Participant
Series B$2.1BAlphabet — Role not disclosedCapitalG — Role not disclosedGV — Role not disclosedMGX — Role not disclosedTemasek — Role not disclosedThrive Capital — Role not disclosedUK Sovereign AI fund — Role not disclosed
Sourcesisomorphiclabs.com ↗